Postmenopausal Osteoporosis
📧 Sign up to get email alerts when something new happens for Postmenopausal Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-02-27Clinical Trial Update: Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women [Phase 4]
This Phase 4 trial update investigates the effects of rosiglitazone on bone health in postmenopausal women with type 2 diabetes; the study s…
-
FDA approval · 2006-12-28FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Fosamax (alendronate sodium) submitted by Organon LLC.
-
FDA approval · 2006-12-15FDA Approved: ELESTRIN — Original Application (Viatris Specialty LLC)
FDA approved ELESTRIN (estradiol) via an original NDA; indicates estrogen replacement therapy for menopausal symptoms and related indication…
-
CLINICAL_TRIALS trial_result · 2006-12-13Clinical Trial Update: Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women [Phase 1]
Phase 1 pharmacokinetics and pharmacodynamics study of oral salmon calcitonin in healthy postmenopausal women to characterize exposure and p…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Effects of Black Cohosh on Menopausal Hot Flashes [Phase 2]
A Phase 2 trial evaluated the effects of black cohosh on menopausal hot flashes in postmenopausal women. The study completed under NCCIH spo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2006-08-11FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approves a supplemental application for Actonel (risedronate sodium) from Allergan, Inc., indicating an approved update to its labeling/…
-
FDA label_change · 2006-07-26FDA Approved: PREMARIN — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PREMARIN (conjugated estrogens), resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2006-07-20Clinical Trial Update: Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis [Phase 3]
Phase 3 trial evaluating the combined use of teriparatide and raloxifene in postmenopausal osteoporosis has completed.